Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Immunology ; 169(1): 102-112, 2023 05.
Artigo em Inglês | MEDLINE | ID: mdl-36440951

RESUMO

Interleukin (IL)-4 signals can modulate mast cells, which express the IL-4Rα chain. The IL-4Rα can heterodimerise with the common γ-chain and utilizes JAK1 and JAK2 for signal transduction, while complexes of IL-4Rα with IL-13Rα1 subunit mediates signals via JAK2 and Tyk2. Here, we report that IL-3 is an essential factor for the continuous expression of the IL-4Rα chain on mast cells, which did not express the IL-13Rα1 chain. We demonstrate that the signals induced by IL-3 important for IL-4Rα expression are mediated by Tyk2 and STAT6 activation and the subsequent maintenance of HSP90 levels. In line with that, inhibition of either Tyk2, STAT6 or HSP90 impaired the IL-3-induced IL-4Rα upregulation. Consequently, the IL-3 maintained IL-4Rα surface expression via Tyk2 is essential for the costimulatory effect of IL-4 on the IL-33-induced production of IL-6 and IL-13.


Assuntos
Interleucina-3 , Mastócitos , Subunidade alfa1 de Receptor de Interleucina-13/metabolismo , Mastócitos/metabolismo , Receptores de Interleucina-13/metabolismo , Receptores de Interleucina-4 , Transdução de Sinais , Fator de Transcrição STAT6/genética , Fator de Transcrição STAT6/metabolismo , Subunidade alfa de Receptor de Interleucina-4/metabolismo , TYK2 Quinase/metabolismo
2.
PLoS One ; 15(6): e0234638, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32569325

RESUMO

Hematopoietic stem cell transplantation is successfully applied since the late 1950s; however, its efficacy still needs to be increased. A promising strategy is to transplant high numbers of pluripotent hematopoietic stem cells (HSCs). Therefore, an improved ex vivo culture system that supports proliferation and maintains HSC pluripotency would override possible limitations in cell numbers gained from donors. To model the natural HSC niche in vitro, we optimized the HSC medium composition with a panel of cytokines and valproic acid and used an artificial 3D bone marrow-like scaffold made of polydimethylsiloxane (PDMS). This 3D scaffold offered a suitable platform to amplify human HSCs in vitro and, simultaneously, to support their viability, multipotency and ability for self-renewal. Silicon oxide-covering of PDMS structures further improved amplification of CD34+ cells, although the conservation of naïve HSCs was better on non-covered 3D PDMS. Finally, we found that HSC cultivated on non-covered 3D PDMS generated most pluripotent colonies within colony forming unit assays. In conclusion, by combining biological and biotechnological approaches, we optimized in vitro HSCs culture conditions, resulting in improved amplification, multipotency maintenance and vitality of HSCs.


Assuntos
Materiais Biomiméticos/farmacologia , Células-Tronco Hematopoéticas/citologia , Nicho de Células-Tronco , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Colágeno/farmacologia , Dimetilpolisiloxanos/farmacologia , Feminino , Fibronectinas/farmacologia , Células-Tronco Hematopoéticas/efeitos dos fármacos , Humanos , Masculino , Purinas/farmacologia , Nicho de Células-Tronco/efeitos dos fármacos , Ácido Valproico/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...